International Pharmaceutical Industry journal speaks with Recipharm about its global oral solid dose (OSD) manufacturing and development capabilities, exploring how ...

International Pharmaceutical Industry journal speaks with Dr Campbell Bunce, Chief Science Officer at Abzena, on the company’s expanded AbZelectPRO™ cell line de...

International Pharmaceutical Industry journal speaks with Márcio Temtem, VP Strategic Business Management at Hovione, about how the company’s deep-rooted expertise i...

In 2016, the Kigali Amendment to the Montreal Protocol set a clear global ambition to phase down the use of hydrofluorocarbons (HFCs) and reduce their environmental ...

International Pharmaceutical Industry journal speaks with Ensera’s Chief Executive Officer, Jason Anderson, on the company’s approach to drug delivery and pharma pac...

Sue Tabbitt elicits some predictions for the year ahead from industry experts. AI will inevitably feature heavily again, but in what context - and where else shou...

An interview with Brian Morrissey, General Manager of Gaelic Laboratories, about the recent deal that put all of Ireland’s Beta-Lactam manufacturing capacity under o...

International Pharmaceutical Industry journal speaks with Symeres’ Chief Commercial Officer, Philip Payne, and Head of Drug Development, Goran Verspui, on the compan...

Sue Tabbitt, senior writer at Sarum Life Sciences reflects on a tumultuous year for technology strategy delivery in life sciences. 2025 has been a trying year...

International Pharmaceutical Industry journal speaks with Ensera’s CEO Jason Anderson at CPHI Frankfurt on the company’s rebrand, strategic evolution, and its ro...